EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis

Gun Ha Kim, Pyeong Hwa Kim, Ji Hoon Shin, In Chul Nam, Hee Ho Chu, Heung-Kyu Ko

European Radiology · 2022-03 · 32 (3) · 1726-1737

DOI: 10.1007/s00330-021-08270-5 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Radiology, online erschienen am 27.09.2021. Verfasst von Gun Ha Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Research Institute of Radiology, College of Medicine, Asan Medical Center, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea. Hauptthemen laut MEDLINE: Endometriosis, Sclerotherapy. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To determine the efficacy and safety of ultrasound (US)-guided sclerotherapy for the treatment of ovarian endometrioma through a systematic review and meta-analysis. METHODS: MEDLINE and EMBASE databases were searched for studies reporting outcomes in patients with endometrioma who were treated with US-guided sclerotherapy. Meta-analyses of recurrence, pain resolution, pregnancy, technical success, and complication rates were analyzed. Subgroup analyses were conducted regarding the indwelling time of sclerotherapy (≤ 10 min vs > 10 min). RESULTS: Twenty-eight studies (1301 patients) were included. The pooled technical efficacy was 98.3%. The pooled estimates of recurrence, pain resolution, and pregnancy rate were 13.8%, 85.9%, and 37.6%, respectively. The pooled major complication rate was 1.7%. A sclerotherapy time > 10 min had a lower pooled recurrence rate than a time ≤ 10 min (11.2% vs 20.9%; p = 0.106). Direct comparisons showed that the recurrence rate was significantly lower with sclerotherapy > 10 min than with sclerotherapy ≤ 10 min (OR, 0.2; p = 0.015). Regarding pregnancy rates, sclerotherapy of > 10 min showed no significant difference compared with sclerotherapy of ≤ 10 min (35.9% vs 38.8%; p = 0.664). Direct comparisons with surgery showed that sclerotherapy increased the pregnancy rate compared with surgery (OR, 2.0; p = 0.042). There was no significant difference in AMH level before and after sclerotherapy (p = 0.951). There was no significant difference in major complication rates between sclerotherapy > 10 min and ≤ 10 min (p = 0.837). CONCLUSION: US-guided sclerotherapy seems to be an effective and safe therapeutic option regarding recurrence, pain resolution, and pregnancy for patients with ovarian endometrioma. KEY POINTS: • US-guided sclerotherapy seems to be an effective and safe therapeutic option regarding recurrence, pain resolution, and pregnancy for patients with ovarian endometrioma. • Sclerotherapy of more than 10 min had a lower recurrence rate than sclerotherapy less than or equal to 10 min. There was no significant difference in major complication rates between sclerotherapy of > 10 min and ≤ 10 min. • Future randomized controlled trials are warranted to compare the outcomes of US-guided sclerotherapy with surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisSclerotherapyEthanolFemaleHumansPregnancyUltrasonographyUltrasonography, Interventional

Stichwörter der Autor:innen

EndometriosisEthanolMeta-analysisOvarySclerotherapy

Substanzen

Ethanol

Autor:innen und Institutionen

  • Department of Radiology and Research Institute of Radiology, College of Medicine, Asan Medical Center, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea.
  • Department of Radiology and Research Institute of Radiology, College of Medicine, Asan Medical Center, Olympic-ro 43-gil, Songpa-gu, Seoul, Korea. jhshin@amc.seoul.kr.
  • Department of Radiology, Gyeongsang National University College of Medicine and Gyeongsang National University Hospital, Changwon, Korea.

Zitieren

APA

Kim, G. H., Kim, P. H., Shin, J. H., Nam, I. C., Chu, H. H., & Ko, H. K. (2022). Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis. European Radiology, 32(3), 1726-1737. https://doi.org/10.1007/s00330-021-08270-5

Vancouver

Kim GH, Kim PH, Shin JH, Nam IC, Chu HH, Ko HK. Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis. European Radiology. 2022;32(3):1726-1737. doi:10.1007/s00330-021-08270-5

BibTeX
@article{Kim2022,
  author = {Kim, Gun Ha and Kim, Pyeong Hwa and Shin, Ji Hoon and Nam, In Chul and Chu, Hee Ho and Ko, Heung-Kyu},
  title = {Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis},
  journal = {European Radiology},
  year = {2022},
  volume = {32},
  number = {3},
  pages = {1726--1737},
  doi = {10.1007/s00330-021-08270-5}
}
Kostenlos starten →